Zynex, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZYXI research report →
Companywww.zynex.com
Zynex, Inc. , through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device.
- CEO
- Steven Lewis Dyson
- IPO
- 2004
- Employees
- 1,000
- HQ
- Englewood, CO, US
Price Chart
Valuation
- Market Cap
- $3.80M
- P/E
- -0.02
- P/S
- 0.02
- P/B
- -0.04
- EV/EBITDA
- -0.93
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 71.64%
- Op Margin
- -62.76%
- Net Margin
- -68.35%
- ROE
- -1807.05%
- ROIC
- -224.51%
Growth & Income
- Revenue
- $192.35M · 4.36%
- Net Income
- $2.99M · -69.24%
- EPS
- $0.09 · -66.67%
- Op Income
- $5.99M
- FCF YoY
- -26.63%
Performance & Tape
- 52W High
- $8.45
- 52W Low
- $0.03
- 50D MA
- $0.93
- 200D MA
- $1.78
- Beta
- 1.00
- Avg Volume
- 7.25M
Get TickerSpark's AI analysis on ZYXI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 26, 26 | MICHAELS BARRY D | sell | 80,001 |
| Mar 26, 26 | Disbrow Joshua R. | sell | 12,499 |
| Mar 26, 26 | Disbrow Joshua R. | sell | 89,501 |
| Mar 26, 26 | Cress Michael D | sell | 12,499 |
| Mar 26, 26 | Cress Michael D | sell | 82,501 |
| Jun 5, 21 | MOORHEAD DANIEL J | other | 5,000 |
| Jun 7, 21 | MOORHEAD DANIEL J | other | 2,314 |
Our ZYXI Coverage
We haven't published any research on ZYXI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ZYXI Report →